Uranga-Romano JG, Hernández-Valencia M, Zárate A, Basavilvazo-Rodríguez MA

Language: Spanish
References: 11
Page: 452-455
PDF size: 273.37 Kb.

ABSTRACT

Background: Endometriosis is the presence of functional endometrial tissue in the pelvic peritoneum and it affects several age groups. That is why the impact of endometriosis in quality of life is considerable. The objective of this study was to evaluate the effectiveness of dienogest in patients with pelvic pain associated to endometriosis (PPAE).
Methods: The evaluation of the effectiveness was carried out through a systematic review using the Cochrane methodology. It was used Markov model, which considers two states of health (with and without PPAE), with the possibility of weekly transition. Women between 18 and 45 years with PPAE were included, in a temporary horizon of 26 weeks. A level of statistical significance of 95% was used for a p ‹ 0.05, with a multivariate probabilistic analysis of sensibility, as well as a univariate analysis of sensibility in several scenarios.
Results: The probability that the female patient did not experience PPAE with the initial treatment was 87.91% with dienogest, 80.07% with danazol, 84.93% with medroxyprogesterone (injectable and oral) and 89.17% with gosereline. The probability that the female patient abandoned her initial treatment was 9% with dienogest, 12.07% with danazol, 9.6 and 6.75% with medroxyprogesterone injectable and oral, respectively, and 10.8 and 3.6% 3-monthly and monthly with gosereline.
Conclusion: Compared to danazol, medroxiprogesterone and gosereline, dienogest is the most efficient alternative to treat PPAE.

REFERENCES

1. Ballweg ML. Big picture of endometriosis helps provide guidance on approach to teens: comparative historical data show endostarting younger, is more severe. J Pediatr Adolesc Gynecol. 2003;16(3 Suppl):S21-6.

2. Hernández-Valencia M. Diagnóstico de la endometriosis. Perinatol Reprod Hum. 2009;23:25-9.

3. Preciado-Ruiz R, Torres-Calleja J, Zúñiga-Montiel JA, Martínez-Chéquer JC, Manterola-Álvarez D, García-Luna A. [Incidence of endometriosis in infertile women: clinical and laparoscopic characteristics]. [Article in Spanish] Ginecol Obstet Mex. 2005 Sep;73(9):471-6.

4. Hernández-Quijano T, Hernández-Valencia M, Zárate- Treviño A, Pérez-Figueroa E. Endometriosis: ¿Es un problema de las señales inmunológicas? Ginecol Obstet Mex. 2005;73:492-9.

5. Sinaii N, Cleary SD, Younes N, Ballweg ML, Stratton P. Treatment utilization for endometriosis symptoms: a cross-sectional survey study of lifetime experience. Fertil Steril. 2007;87(6):1277-86.

6. Hernández-Valencia M, Zárate A, Hernández QT, Landero MOME, Escamilla GG. Endometriosis en cicatriz tardía de episiorrafia postparto eutócico. Aspectos integrales y reporte de un caso. Rev Med Inst Mex Seguro Soc. 2005;43(3):237-42.

7. Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C. Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis. Int J Gynaecol Obstet. 2012 Jun;117(3):228-33.

8. Hernández-Valencia M, Zárate A. Endometriosis. Base fisiopatogénica para el tratamiento. Rev Med Inst Mex Seguro Soc. 2009;47(1):57-60.

9. Strowitzki T, Faustmann T, Gerlinger C, Seitz C. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol. 2010;151(2):193-8.

10. Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod. 2010;25(3):633-41. 12. ACOG Committee on Practice Bulletins-Gynecology. ACOG practice bulletin. Medical management of endometriosis. Number 11, December 1999 (replaces Technical Bulletin Number 184, September 1993). Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet. 2000 Nov;71(2):183-96.

11. Brown J, Kives S, Akhtar M. Progestagens and antiprogestagens for pain associated with endometriosis. Cochrane Database Syst Rev. 2012 Mar 14;(3): CD002122